Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Muller

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Progress in Cardiovascular Diseases|May 25, 2002
Triggers of acute coronary syndromesStephen J Servoss, James L Januzzi, James E Muller
JACC. Cardiovascular Imaging|August 14, 2010
The year in intracoronary imagingJames E Muller, Neil J Weissman, E Murat Tuzcu
Journal of the American College of Cardiology|April 25, 2006
New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaquesJames E Muller, Ahmed Tawakol, Sekar Kathiresan, et al.
Circulation|December 21, 2005
Binge drinking and mortality after acute myocardial infarctionKenneth J Mukamal, Malcolm Maclure, James E Muller, et al.
Journal of the American College of Cardiology|April 25, 2006
Near-infrared spectroscopy for the detection of vulnerable coronary artery plaquesJay D Caplan, Sergio Waxman, Richard W Nesto, et al.
American Heart Journal|February 26, 2008
An exploratory prospective study of marijuana use and mortality following acute myocardial infarctionKenneth J Mukamal, Malcolm Maclure, James E Muller, et al.
Circulation|May 17, 2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph Omato, James E Muller, Erika S Froelicher, et al.
Expert Opinion on Investigational Drugs|May 9, 2002
Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaquesDavid E Sosnovik, James E Muller, Sekar Kathiresan, et al.
Journal of the American College of Cardiology|March 31, 2007
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph P Ornato, James E Muller, Erika S Froelicher, et al.
Journal of the American College of Cardiology|June 12, 2003
34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques?Allen P Burke, Renu Virmani, Zorina Galis, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Progress in Cardiovascular Diseases|May 25, 2002
Triggers of acute coronary syndromesStephen J Servoss, James L Januzzi, James E Muller
JACC. Cardiovascular Imaging|August 14, 2010
The year in intracoronary imagingJames E Muller, Neil J Weissman, E Murat Tuzcu
Journal of the American College of Cardiology|April 25, 2006
New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaquesJames E Muller, Ahmed Tawakol, Sekar Kathiresan, et al.
Circulation|December 21, 2005
Binge drinking and mortality after acute myocardial infarctionKenneth J Mukamal, Malcolm Maclure, James E Muller, et al.
Journal of the American College of Cardiology|April 25, 2006
Near-infrared spectroscopy for the detection of vulnerable coronary artery plaquesJay D Caplan, Sergio Waxman, Richard W Nesto, et al.
American Heart Journal|February 26, 2008
An exploratory prospective study of marijuana use and mortality following acute myocardial infarctionKenneth J Mukamal, Malcolm Maclure, James E Muller, et al.
Circulation|May 17, 2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph Omato, James E Muller, Erika S Froelicher, et al.
Expert Opinion on Investigational Drugs|May 9, 2002
Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaquesDavid E Sosnovik, James E Muller, Sekar Kathiresan, et al.
Journal of the American College of Cardiology|March 31, 2007
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph P Ornato, James E Muller, Erika S Froelicher, et al.
Journal of the American College of Cardiology|June 12, 2003
34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques?Allen P Burke, Renu Virmani, Zorina Galis, et al.
Pageof 10